Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 49 % of short-term debt in 2022; threshold 65 %.
-
Figures corrected NBB
Corrected annual account filed for 2019.
-
Late annual account NBB
Fiscal year 2022 was filed 211 days after the legal deadline.
-
Annual account missing NBB
Fiscal year 2023 was expected before 31 July 2024 and has not been filed.
Financials
Financial year 2022
MG PHARMA from Vorst, company number BE0427381406, closed financial year 2022 with a result of € -3,795 after tax. For that financial year MG PHARMA recorded a gross margin of € 19,525 and equity of € 167,812. Compared with financial year 2021, the result moved from € 19,757 to € -3,795. The company made a loss. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on February 27, 2024.
€ 167,812
▼ 2% vs 2021
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -3,795
▼ still € 19,757 profit in 2021
Profit after tax over the fiscal year.
€ 6,290
▲ 74% vs 2021
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € 149,220.
Debts at end 2022
€ 369,959
▲ 8% vs 2021
Loans from banks and other lenders, long and short.
€ 445,997
▲ 13% vs 2021
Supplier invoices still open on the last day of the fiscal year.
€ 117,001
▲ 230% vs 2021
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2019 | 2021 | 2022 | Change 2021 → 2022 | |
|---|---|---|---|---|
| Gross margin | € 33,331 | € 57,626 | € 19,525 | ▼ 66% |
| Profit after taxes | € 4,302 | € 19,757 | € -3,795 | ▼ € 23,552 |
| Equity | € 180,801 | € 171,607 | € 167,812 | ▼ 2% |
| Total debts | € 1,136,762 | € 865,930 | € 932,957 | ▲ 8% |
| Cash | € 25,367 | € 3,612 | € 6,290 | ▲ 74% |
| Land & buildings | € 180,200 | € 159,000 | € 148,400 | ▼ 7% |
| Retained profit | € 162,209 | € 153,015 | € 149,220 | ▼ 2% |
| Bank debt | € 478,535 | € 343,818 | € 369,959 | ▲ 8% |
| Balance sheet total | € 1,317,564 | € 1,037,537 | € 1,100,769 | ▲ 6% |
Key figures of MG PHARMA, fiscal years 2019 to 2022, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2023 has not been filed yet; it was expected before 31 July 2024.
What happened to MG PHARMA?
What happened at MG PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2022: loss of € 3,795 (▼ € 23,552 vs 2021). filed late Source: NBB ↗
- New establishment in Watermaal-Bosvoorde. KBO
- Start of the company according to the CBE. KBO
In short
From € 4,302 profit in 2019 to € 3,795 loss in 2022.
Paid € 15,402 in corporate taxes since 2019.
Best year ever: 2021, with € 19,757 profit.
A new publication or filing at MG PHARMA? We notify you, reason included.
Follow MG PHARMADatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Establishments
Establishment units
Physical locations of this company
Molièrelaan 10
1190 Vorst
Onze-Lieve-Heersbeestjeslaan 98
1170 Watermaal-Bosvoorde
Active since 4 June 1985
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0427.381.406
- VAT number
- BE 0427.381.406
- Registered office
- Molièrelaan 10, 1190 Vorst
- Names & denominations
- MG PHARMA
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 4 June 1985
- Peppol
- Active · Active since 29 Dec 2025